What is the Ownership and Shareholding Structure of Sunglow Lifescience?
In 2024, Sunglow Lifescience had a promoter holding of 13.69% and a public holding of 86.31%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.










Company Details
+91-XXXXXXXXXX